Asso.Dh
ASSO.DH is a chemicals company that produces and sells commodity chemicals, generating revenue primarily through the sale of chemical products to industrial and manufacturing customers.
Business. ASSO.DH is a chemicals company that produces and sells commodity chemicals, generating revenue primarily through the sale of chemical products to industrial and manufacturing customers.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
ASSO.DH is a chemicals company that produces and sells commodity chemicals, generating revenue primarily through the sale of chemical products to industrial and manufacturing customers.
The company maintains a strong capital structure with a low debt-to-equity ratio of 0.02, indicating minimal reliance on debt financing. However, its liquidity position is assessed as medium, with a current ratio of 3.07, suggesting the company has sufficient short-term assets to cover its liabilities, but not in excess. Free cash flow is negative at -123.6 million, driven by a large capital expenditure of -391.7 million, which may signal ongoing investment in infrastructure or expansion.
Profitability metrics show a return on equity of 9.06% and a return on assets of 7.95%, both of which are strong indicators of efficient use of equity and assets to generate profit. These figures suggest the company is performing well relative to its capital base, though a direct comparison to industry medians is required to fully assess its competitive position.
The company's revenue is concentrated in the chemicals segment, with no disclosed geographic breakdown. This lack of diversification may expose the company to regional or sector-specific risks, particularly in volatile commodity markets. The absence of segment or geographic data limits the ability to assess exposure to specific markets or products.
Looking ahead, the company is expected to maintain a stable revenue trajectory, with no significant growth or decline projected in the next fiscal year. The capital expenditure of -391.7 million suggests a focus on maintaining or expanding production capacity, which could support long-term growth. However, the negative free cash flow indicates that the company is currently reinvesting heavily, which may impact short-term shareholder returns.
Risk factors include a medium liquidity risk, primarily due to the negative net cash position after subtracting total debt. While the company has a low dilution risk, the potential for future dilution exists if the company issues additional shares to fund operations or expansion. The risk assessment also highlights the importance of monitoring capital structure decisions to ensure continued financial stability.
Recent events, including the latest financial filing, show a strong operating cash flow of 341.9 million, which supports the company's ability to fund operations and investments. No recent transcripts or filings indicate significant changes in strategy or operations, suggesting a stable business environment for the company.
- The company has a strong return on equity and assets, indicating efficient use of capital.
- A low debt-to-equity ratio suggests a conservative capital structure.
- Negative free cash flow and high capital expenditure indicate ongoing investment in the business.
- The company's liquidity is assessed as medium, with a current ratio of 3.07.
- Revenue concentration in the chemicals segment may expose the company to sector-specific risks.
- No significant dilution risk is currently present, but future capital needs may require additional equity issuance.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- ASSO.DH Market data — financials · 2026-05-27